☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Rare
Innovate Merging with RDD Pharma to Form New Gastroenterology Company Focusing on Specialty Rare and Orphan Diseases
October 8, 2019
Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal
April 8, 2019
Roche's MabThera (rituximab) Receives EU's Approval for Rare Autoimmune Disease Pemphigus Vulgaris (PV)
March 15, 2019
Axovant Sciences Licenses Two Gene Therapy Programs from University of Massachusetts for Rare and Fatal Neurodegenerative Genetic...
December 14, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.